Whooping cough vaccination in adolescents and adults: A strategy required by epidemiology;Vacunación frente a la tos ferina en el adolescente y adulto: Una estrategia marcada por la epidemiología

Vacunas

Volumn 8, Issue 1, 2007, Pages 1-2

  Salleras, L ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ADULT DISEASE; EDITORIAL; HUMAN; INFECTION PREVENTION; PERTUSSIS; VACCINATION;

EID: 37849007381     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(07)73962-6     Document Type: Editorial

References (29)

1. Edwards KM, Decker MD. Pertussis vaccine. En: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders; 2004.
2. a ed. española. Madrid: Acindes; 2007. p. 1411-36.
3. Salleras L. Vacunaciones del adolescente. En: Salleras L, editor. Barcelona: Masson; 2003. p. 931-46.
4. a ed. Barcelona: Masson; 2003. p. 139-62.
5. Brown F, Greco D, Mastrantonio P, Salmaso S, Wasilak S. Pertussis Vaccine Trials. Dev Biol Stand. 1997;89:14-23.
6. Comité de Vacunas de la Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Salleras L (coordinador), Bayas JM, Calbo F, Campins M, Castrodeza J, Cerrillo A, et al. Vacunación anti-tos ferina de los adolescentes y adultos. Vacunas. 2007;1:38-47.
7. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt H. Pertussis in adults: frecuency of transmisión after household exposure. Lancet. 1995;346:1326-9.
8. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet. 2002;2:744-50.
9. Halperin SA. The control of pertussis-2007 and beyond. N Engl J Med. 2007:356:110-3.
10. Halperin SA. Pertussis - A disease and vaccine for all ages. N Engl J Med. 2005;353:1615-7.
11. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis. J 2006;25:361-2.
12. Wheeler JG, Simmons AL. Pertussis update. Pediatr Infect Dis J. 2005;24:829-30.
13. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005;24:721-8.
14. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachsjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults 1990-1996. Clin Infect Dis. 1999;28:1230-7.
15. Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms and implications for vaccination. Clin Ifect Dis. 1999;28 Suppl 2:S147-50.
16. Edwards KM. Pertussis in older children and adults. Advan Ped Infect Dis. 1998;13:49-77.
17. Keitel WA, Edwards KM. Pertussis in adolescents and adults: Time to reimmunize. Semin Resp Infect. 1995;10:51-7.
18. Romero M, Domínguez A, Cardeñosa N, Carmona G, Codina G, Fuentes M, and the Catalonia Pertussis Working Group. Detection of cases of pertussis by a surveillance programme: revaccination concerns [poster P-1]. Fifth World Congreso on Vaccines, Immunization and Immunotherapy (WCVII 2006 CANADA). Montreal, 6-9 november 2006.
19. th World Congres of the World Society for Pediatric Infectious Diseases (WSPID). Varsovia (Polonia), september 1-4, 2005.
20. Kowalkiz F, Barbosa AP, Fernández VR, Carvalho PR, Avila-Agüero ML, Goh DYT, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Ped Infect Dis J. 2007 [en prensa].
21. Forsyth K. Prevention of pertussis. Recommendaions derived from the Second Global Pertussis Roundtable Meeting. Vaccine. 2007;25:2634-42.
22. Campins M, Moraga FA. La tos ferina en el adolescente y el adulto. Epidemiología e implicaciones para la vacunación. Med Clin (Barc). 2000;114:661-4.
23. Campins M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. Vaccine. 2001;20:641-6.
24. Forsyth KD, Campins-Marti M, Caro J, Cherry JD, Greenberg D, Guiso N, et al. New pertussis vaccination strategies beyond infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis. 2004;39:1802-9.
25. Centers for Disease Control. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(RR-3):1-44.
26. Centers for Disease Control. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel. MMWR. 2006;55(RR-17):1-33.
27. Centers for Disease Control. Recommended adult immunization schedule-United States, October 2006-September 2007. MMWR 2006;55:Q1-Q4.
28. Centers for Disease Control. Recommended Immunization Schedules for Persons Aged 0 to 18 Years-United States, 2007. MMWR. 2007;55:Q1-Q4.
29. Public Health Agency of Canada. An Advisory Committee Statment (ACS). National Advisory Committee on Immunization (NACI). Prevention of pertussis in adolescents and adults. Can Commun Dis Rep. 2003;29:1-9.